Impact  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
a  ||| S:10 E:12 ||| DT
5-year  ||| S:12 E:19 ||| JJ
deferral  ||| S:19 E:28 ||| NN
from  ||| S:28 E:33 ||| IN
blood  ||| S:33 E:39 ||| NN
donation  ||| S:39 E:48 ||| NN
for  ||| S:48 E:52 ||| IN
men  ||| S:52 E:56 ||| NNS
who  ||| S:56 E:60 ||| WP
have  ||| S:60 E:65 ||| VBP
sex  ||| S:65 E:69 ||| NN
with  ||| S:69 E:74 ||| IN
men  ||| S:74 E:78 ||| NNS
The  ||| S:78 E:82 ||| DT
deferral  ||| S:82 E:91 ||| NN
for  ||| S:91 E:95 ||| IN
men  ||| S:95 E:99 ||| NNS
who  ||| S:99 E:103 ||| WP
have  ||| S:103 E:108 ||| VBP
sex  ||| S:108 E:112 ||| NN
with  ||| S:112 E:117 ||| IN
men  ||| S:117 E:121 ||| NNS
( ||| S:121 E:122 ||| -LRB-
MSM ||| S:122 E:125 ||| NNP
)  ||| S:125 E:127 ||| -RRB-
changed  ||| S:127 E:135 ||| VBN
from  ||| S:135 E:140 ||| IN
a  ||| S:140 E:142 ||| DT
permanent  ||| S:142 E:152 ||| JJ
deferral  ||| S:152 E:161 ||| NN
since  ||| S:161 E:167 ||| IN
1977  ||| S:167 E:172 ||| CD
to  ||| S:172 E:175 ||| TO
a  ||| S:175 E:177 ||| DT
5-year  ||| S:177 E:184 ||| JJ
deferral  ||| S:184 E:193 ||| NN
on  ||| S:193 E:196 ||| IN
July  ||| S:196 E:201 ||| NNP
22 ||| S:201 E:203 ||| CD
,  ||| S:203 E:205 ||| ,
2013 ||| S:205 E:209 ||| CD
,  ||| S:209 E:211 ||| ,
in  ||| S:211 E:214 ||| IN
Canada ||| S:214 E:220 ||| NNP
.  ||| S:220 E:222 ||| .
We  ||| S:222 E:225 ||| PRP
assessed  ||| S:225 E:234 ||| VBD
the  ||| S:234 E:238 ||| DT
impact  ||| S:238 E:245 ||| NN
on  ||| S:245 E:248 ||| IN
safety  ||| S:248 E:255 ||| NN
and  ||| S:255 E:259 ||| CC
adequacy  ||| S:259 E:268 ||| NN
of  ||| S:268 E:271 ||| IN
the  ||| S:271 E:275 ||| DT
blood  ||| S:275 E:281 ||| NN
supply  ||| S:281 E:288 ||| NN
at  ||| S:288 E:291 ||| IN
Canadian  ||| S:291 E:300 ||| NNP
Blood  ||| S:300 E:306 ||| NNP
Services ||| S:306 E:314 ||| NNPS
.  ||| S:314 E:316 ||| .
Human  ||| S:316 E:322 ||| JJ
immunodeficiency  ||| S:322 E:339 ||| JJ
virus  ||| S:339 E:345 ||| NN
( ||| S:345 E:346 ||| -LRB-
HIV ||| S:346 E:349 ||| NNP
)  ||| S:349 E:351 ||| -RRB-
rates  ||| S:351 E:357 ||| NNS
were  ||| S:357 E:362 ||| VBD
monitored  ||| S:362 E:372 ||| VBN
from  ||| S:372 E:377 ||| IN
January  ||| S:377 E:385 ||| NNP
1 ||| S:385 E:386 ||| CD
,  ||| S:386 E:388 ||| ,
2010 ||| S:388 E:392 ||| CD
,  ||| S:392 E:394 ||| ,
to  ||| S:394 E:397 ||| TO
July  ||| S:397 E:402 ||| NNP
21 ||| S:402 E:404 ||| CD
,  ||| S:404 E:406 ||| ,
2015 ||| S:406 E:410 ||| CD
.  ||| S:410 E:412 ||| .
Risk  ||| S:412 E:417 ||| NN
factors  ||| S:417 E:425 ||| NNS
were  ||| S:425 E:430 ||| VBD
assessed  ||| S:430 E:439 ||| VBN
in  ||| S:439 E:442 ||| IN
notification  ||| S:442 E:455 ||| NN
interviews ||| S:455 E:465 ||| NNS
.  ||| S:465 E:467 ||| .
Anonymous  ||| S:467 E:477 ||| JJ
online  ||| S:477 E:484 ||| JJ
surveys  ||| S:484 E:492 ||| NNS
of  ||| S:492 E:495 ||| IN
male  ||| S:495 E:500 ||| JJ
whole  ||| S:500 E:506 ||| JJ
blood  ||| S:506 E:512 ||| NN
donors  ||| S:512 E:519 ||| NNS
assessed  ||| S:519 E:528 ||| VBN
compliance  ||| S:528 E:539 ||| NN
before  ||| S:539 E:546 ||| IN
and  ||| S:546 E:550 ||| CC
after  ||| S:550 E:556 ||| IN
implementation ||| S:556 E:570 ||| NN
.  ||| S:570 E:572 ||| .
HIV  ||| S:572 E:576 ||| NNP
rates  ||| S:576 E:582 ||| NNS
were  ||| S:582 E:587 ||| VBD
0.2 ||| S:587 E:590 ||| CD
,  ||| S:590 E:592 ||| ,
0.5 ||| S:592 E:595 ||| CD
,  ||| S:595 E:597 ||| ,
and  ||| S:597 E:601 ||| CC
0.51  ||| S:601 E:606 ||| CD
per  ||| S:606 E:610 ||| IN
100,000  ||| S:610 E:618 ||| CD
donations  ||| S:618 E:628 ||| NNS
in  ||| S:628 E:631 ||| IN
2010  ||| S:631 E:636 ||| CD
to  ||| S:636 E:639 ||| TO
2012 ||| S:639 E:643 ||| CD
;  ||| S:643 E:645 ||| :
they  ||| S:645 E:650 ||| PRP
were  ||| S:650 E:655 ||| VBD
0.54  ||| S:655 E:660 ||| CD
and  ||| S:660 E:664 ||| CC
0.22  ||| S:664 E:669 ||| CD
in  ||| S:669 E:672 ||| IN
the  ||| S:672 E:676 ||| DT
first  ||| S:676 E:682 ||| JJ
and  ||| S:682 E:686 ||| CC
second  ||| S:686 E:693 ||| JJ
years  ||| S:693 E:699 ||| NNS
after  ||| S:699 E:705 ||| IN
implementation  ||| S:705 E:720 ||| NN
( ||| S:720 E:721 ||| -LRB-
p  ||| S:721 E:723 ||| CD
=  ||| S:723 E:725 ||| CD
0.8 ||| S:725 E:728 ||| CD
) ||| S:728 E:729 ||| -RRB-
.  ||| S:729 E:731 ||| .
Of  ||| S:731 E:734 ||| IN
four  ||| S:734 E:739 ||| CD
male  ||| S:739 E:744 ||| JJ
HIV-positive  ||| S:744 E:757 ||| JJ
donors  ||| S:757 E:764 ||| NNS
after  ||| S:764 E:770 ||| IN
implementation ||| S:770 E:784 ||| NN
,  ||| S:784 E:786 ||| ,
three  ||| S:786 E:792 ||| CD
denied  ||| S:792 E:799 ||| JJ
risk  ||| S:799 E:804 ||| NN
factors  ||| S:804 E:812 ||| NNS
and  ||| S:812 E:816 ||| CC
one  ||| S:816 E:820 ||| PRP
knew  ||| S:820 E:825 ||| VBD
he  ||| S:825 E:828 ||| PRP
had  ||| S:828 E:832 ||| VBD
HIV ||| S:832 E:835 ||| NNP
.  ||| S:835 E:837 ||| .
Before  ||| S:837 E:844 ||| IN
implementation  ||| S:844 E:859 ||| CD
9669  ||| S:859 E:864 ||| CD
of  ||| S:864 E:867 ||| IN
19,437  ||| S:867 E:874 ||| NNP
( ||| S:874 E:875 ||| -LRB-
49.7 ||| S:875 E:879 ||| CD
% ||| S:879 E:880 ||| NN
)  ||| S:880 E:882 ||| -RRB-
donors  ||| S:882 E:889 ||| NNS
participated  ||| S:889 E:902 ||| VBD
in  ||| S:902 E:905 ||| IN
the  ||| S:905 E:909 ||| DT
survey ||| S:909 E:915 ||| NN
,  ||| S:915 E:917 ||| ,
and  ||| S:917 E:921 ||| CC
after  ||| S:921 E:927 ||| IN
implementation ||| S:927 E:941 ||| NN
,  ||| S:941 E:943 ||| ,
6881  ||| S:943 E:948 ||| CD
of  ||| S:948 E:951 ||| IN
18,934  ||| S:951 E:958 ||| NNP
( ||| S:958 E:959 ||| -LRB-
36.3 ||| S:959 E:963 ||| CD
% ||| S:963 E:964 ||| NN
) ||| S:964 E:965 ||| -RRB-
.  ||| S:965 E:967 ||| .
Before  ||| S:967 E:974 ||| IN
implementation  ||| S:974 E:989 ||| CD
0.67 ||| S:989 E:993 ||| CD
%  ||| S:993 E:995 ||| NN
of  ||| S:995 E:998 ||| IN
male  ||| S:998 E:1003 ||| JJ
donors  ||| S:1003 E:1010 ||| NNS
were  ||| S:1010 E:1015 ||| VBD
noncompliant ||| S:1015 E:1027 ||| CD
,  ||| S:1027 E:1029 ||| ,
and  ||| S:1029 E:1033 ||| CC
after  ||| S:1033 E:1039 ||| IN
implementation ||| S:1039 E:1053 ||| NN
,  ||| S:1053 E:1055 ||| ,
0.44 ||| S:1055 E:1059 ||| CD
% ||| S:1059 E:1060 ||| NN
.  ||| S:1060 E:1062 ||| .
There  ||| S:1062 E:1068 ||| EX
was  ||| S:1068 E:1072 ||| VBD
no  ||| S:1072 E:1075 ||| DT
difference  ||| S:1075 E:1086 ||| NN
before  ||| S:1086 E:1093 ||| IN
versus  ||| S:1093 E:1100 ||| NN
after  ||| S:1100 E:1106 ||| IN
implementation  ||| S:1106 E:1121 ||| NN
in  ||| S:1121 E:1124 ||| IN
male  ||| S:1124 E:1129 ||| JJ
donors  ||| S:1129 E:1136 ||| NNS
with  ||| S:1136 E:1141 ||| IN
MSM  ||| S:1141 E:1145 ||| NNP
history  ||| S:1145 E:1153 ||| NN
in  ||| S:1153 E:1156 ||| IN
the  ||| S:1156 E:1160 ||| DT
past  ||| S:1160 E:1165 ||| JJ
5  ||| S:1165 E:1167 ||| CD
years  ||| S:1167 E:1173 ||| NNS
( ||| S:1173 E:1174 ||| -LRB-
0.37 ||| S:1174 E:1178 ||| CD
%  ||| S:1178 E:1180 ||| NN
vs.  ||| S:1180 E:1184 ||| IN
0.43 ||| S:1184 E:1188 ||| CD
% ||| S:1188 E:1189 ||| NN
,  ||| S:1189 E:1191 ||| ,
p  ||| S:1191 E:1193 ||| CD
=  ||| S:1193 E:1195 ||| CD
0.54 ||| S:1195 E:1199 ||| CD
) ||| S:1199 E:1200 ||| -RRB-
.  ||| S:1200 E:1202 ||| .
After  ||| S:1202 E:1208 ||| IN
implementation ||| S:1208 E:1222 ||| NN
,  ||| S:1222 E:1224 ||| ,
eligible  ||| S:1224 E:1233 ||| JJ
MSM  ||| S:1233 E:1237 ||| NN
donors  ||| S:1237 E:1244 ||| NNS
increased  ||| S:1244 E:1254 ||| VBD
( ||| S:1254 E:1255 ||| -LRB-
0.42 ||| S:1255 E:1259 ||| NNP
%  ||| S:1259 E:1261 ||| NN
vs.  ||| S:1261 E:1265 ||| IN
0.66 ||| S:1265 E:1269 ||| CD
% ||| S:1269 E:1270 ||| NN
,  ||| S:1270 E:1272 ||| ,
p  ||| S:1272 E:1274 ||| CD
=  ||| S:1274 E:1276 ||| CD
0.04 ||| S:1276 E:1280 ||| CD
) ||| S:1280 E:1281 ||| -RRB-
,  ||| S:1281 E:1283 ||| ,
with  ||| S:1283 E:1288 ||| IN
approximately  ||| S:1288 E:1302 ||| RB
500  ||| S:1302 E:1306 ||| CD
more  ||| S:1306 E:1311 ||| JJR
donors  ||| S:1311 E:1318 ||| NNS
in  ||| S:1318 E:1321 ||| IN
2014 ||| S:1321 E:1325 ||| CD
.  ||| S:1325 E:1327 ||| .
Implementation  ||| S:1327 E:1342 ||| NN
of  ||| S:1342 E:1345 ||| IN
a  ||| S:1345 E:1347 ||| DT
5-year  ||| S:1347 E:1354 ||| JJ
deferral  ||| S:1354 E:1363 ||| NN
for  ||| S:1363 E:1367 ||| IN
MSM  ||| S:1367 E:1371 ||| NNP
had  ||| S:1371 E:1375 ||| VBD
no  ||| S:1375 E:1378 ||| DT
impact  ||| S:1378 E:1385 ||| NN
on  ||| S:1385 E:1388 ||| IN
HIV  ||| S:1388 E:1392 ||| NNP
rates  ||| S:1392 E:1398 ||| NNS
in  ||| S:1398 E:1401 ||| IN
2  ||| S:1401 E:1403 ||| CD
years  ||| S:1403 E:1409 ||| NNS
of  ||| S:1409 E:1412 ||| IN
postimplementation  ||| S:1412 E:1431 ||| JJ
monitoring ||| S:1431 E:1441 ||| NN
.  ||| S:1441 E:1443 ||| .
Donor  ||| S:1443 E:1449 ||| JJ
compliance  ||| S:1449 E:1460 ||| NN
improved  ||| S:1460 E:1469 ||| VBN
after  ||| S:1469 E:1475 ||| IN
implementation  ||| S:1475 E:1490 ||| JJ
due  ||| S:1490 E:1494 ||| JJ
to  ||| S:1494 E:1497 ||| TO
MSM  ||| S:1497 E:1501 ||| NNP
donors  ||| S:1501 E:1508 ||| NNS
who  ||| S:1508 E:1512 ||| WP
were  ||| S:1512 E:1517 ||| VBD
previously  ||| S:1517 E:1528 ||| RB
ineligible  ||| S:1528 E:1539 ||| VBP
becoming  ||| S:1539 E:1548 ||| VBG
eligible ||| S:1548 E:1556 ||| JJ
.  ||| S:1556 E:1558 ||| .
There  ||| S:1558 E:1564 ||| EX
was  ||| S:1564 E:1568 ||| VBD
no  ||| S:1568 E:1571 ||| DT
change  ||| S:1571 E:1578 ||| NN
in  ||| S:1578 E:1581 ||| IN
the  ||| S:1581 E:1585 ||| DT
percentage  ||| S:1585 E:1596 ||| NN
of  ||| S:1596 E:1599 ||| IN
male  ||| S:1599 E:1604 ||| JJ
donors  ||| S:1604 E:1611 ||| NNS
with  ||| S:1611 E:1616 ||| IN
recent  ||| S:1616 E:1623 ||| JJ
male  ||| S:1623 E:1628 ||| JJ
partners  ||| S:1628 E:1637 ||| NNS
but  ||| S:1637 E:1641 ||| CC
there  ||| S:1641 E:1647 ||| EX
was  ||| S:1647 E:1651 ||| VBD
a  ||| S:1651 E:1653 ||| DT
modest  ||| S:1653 E:1660 ||| JJ
increase  ||| S:1660 E:1669 ||| NN
in  ||| S:1669 E:1672 ||| IN
eligible  ||| S:1672 E:1681 ||| JJ
MSM  ||| S:1681 E:1685 ||| NN
in  ||| S:1685 E:1688 ||| IN
the  ||| S:1688 E:1692 ||| DT
donor  ||| S:1692 E:1698 ||| NN
pool ||| S:1698 E:1702 ||| NN
.  ||| S:1702 E:1704 ||| .
